Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €28.45 EUR
Change Today -0.02 / -0.07%
Volume 0.0
CUP On Other Exchanges
Symbol
Exchange
OTC US
OTC US
Frankfurt
As of 1:36 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by CHUGAI PHARMACEUTICAL CO LTD (CUP) in the last 6 months

Announced 04/3/15
Chugai Pharmaceutical Co. Ltd., Manufacturing and Marketing Approval Right of Two Antithyroid Drugs
Merger/Acquisition

ASKA Pharmaceutical Co.Ltd. (TSE:4514) signed a contract to acquire manufacturing and marketing approval right of two antithyroid drugs from Chugai Pharmaceutical Co. Ltd. (TSE:4519) on April 3, 2015. The transaction is expected to close on October 1, 2015.


CUP's price was unchanged after the transaction was announced on 04/3/15.
Investor / Buyer
ASKA Pharmaceutical Co.Ltd.
Creditor / Lender
Chugai Pharmaceutical Co. Ltd.
 
Announced 02/28/15
1.42B for iPS PORTAL,Inc.
Private Placement

iPS Portal, Inc. announced the signing of a share subscription agreement for the issue of A class preferred shares for gross proceeds of ¥1.42 billion in the end of February 2015. The transaction included participation from 13 investors, Shimadzu Corporation, Eisai Co., Ltd., Ajinomoto Co., Inc., Sysmex Corporation, Shin Nippon Biomedical Laboratories, Ltd., SCREEN Holdings Co., Ltd., Toho Holdings Co., Ltd., Chugai Pharmaceutical Co., Ltd., Horiba, Ltd., Daiichi Jitsugyo ...
Read More


CUP's price was unchanged after the transaction was announced on 02/28/15.
Investor / Buyer
Ajinomoto Co., Inc.
Chugai Pharmaceutical Co. Ltd.
Daiichi Jitsugyo Co. Ltd.
Daiwa Corporate Investment Co., Ltd.
Eisai Co., Ltd.
HORIBA, Ltd.
SCREEN Holdings Co., Ltd.
Shimadzu Corporation
Shin Nippon Biomedical Laboratories, Ltd.
SMBC Venture Capital Co., Ltd.
Sumitomo Mitsui Banking Corp., Investment Arm
Sysmex Corp.
Toho Holdings Co., Ltd.
 
Announced 02/24/15
500.00M for NanoCarrier Co., Ltd.
Private Placement

NanoCarrier Co., Ltd. (TSE:4571) announced a private placement of 389,400 shares at ¥1,284 per share with new investor, Chugai Pharmaceutical Co. Ltd. for gross proceeds of ¥499,989,600 on February 24, 2015. The investor will acquire 0.96% stake of the company through this transaction. The net proceeds from the transaction will be ¥494,989,600, after deducting estimated amount of issuance fees of ¥5,000,000, which includes registration fees and license taxes ¥ 2,500,000 ...
Read More


CUP's price was unchanged after the transaction was announced on 02/24/15.
Investor / Buyer
Chugai Pharmaceutical Co. Ltd.
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CUP:GR €28.45 EUR -0.02

CUP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CUP.
View Industry Companies
 

Industry Analysis

CUP

Industry Average

Valuation CUP Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHUGAI PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.